Comparison Of Dexmedetomidine And Dexamethasone As An Adjuvant To Bupivacaine In Brachial Plexus Block

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 22, 2021

Primary Completion Date

January 1, 2022

Study Completion Date

January 30, 2022

Conditions
Brachial Plexus BlockDexmedetomidineDexamethasoneBupivacaine
Interventions
PROCEDURE

adding Dexmedetomidine and dexamethasone to bupivacaine in USG guided supraclavicular brachial plexus block.

The linear transducer probe (frequency 4 -12 Hz) of USG machine will be used. A superficial skin wheal will be made by 2ml of 1% lignocaine subcutaneously at the point of needle insertion. USG guided Brachial plexus block will be performed by supraclavicular route via the subclavian perivascular approach in in-plane technique from lateral to medial using 22 gauge spinal needle. Study Drug will be administered via Pressure Monitoring line connected to syringe according to the allocated group with repeated aspiration and incremental dosing. • Intercostobrachial nerve block will be performed to alleviate the tourniquet pain. A 25 G needle will be inserted at the level of axillary fossa. The entire width of the medial aspect of arm, starting at the deltoid prominence and proceeding inferiorly, will be infiltrated with 5ml of 1% Lignocaine with Epinephrine (1:4,00,000) to raise a subcutaneous wheal. •

Trial Locations (1)

44600

Tribhuvan University Teaching Hospital, Kathmandu

All Listed Sponsors
lead

Tribhuvan University Teaching Hospital, Institute Of Medicine.

OTHER

NCT04791475 - Comparison Of Dexmedetomidine And Dexamethasone As An Adjuvant To Bupivacaine In Brachial Plexus Block | Biotech Hunter | Biotech Hunter